Accompanying the increased use of biological and non-biological antirheumatic drugs, a
greater number of cases of hepatitis B virus (HBV) reactivation have been reported in …

Background Screening and prophylactic treatment for hepatitis B virus (HBV) reactivation is
recommended for patients who receive immunosuppressive or cytotoxic therapy. The aim of …

Hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients undergoing
biological therapy is not infrequent. This condition can occur in patients with chronic …

Hepatitis B Reactivation in Rheumatic Diseases - Rheumatic Disease Clinics Skip to Main
Content Skip to Main Menu Advertisement Rheumatic Disease Clinics Log in Register Log in …

Objective The purpose of this study was to determine hepatitis B virus (HBV) screening rates
in patients receiving anti‐tumor necrosis factor (TNF)‐α therapy and the frequency of HBV …

Background. Immunosuppressants can induce hepatitis B virus (HBV) reactivation; however,
informative data about the risk of different immunosuppressive regimens, including …

In patients with rheumatic diseases undergoing immunosuppressive treatment, hepatitis B
virus reactivation (HBVr) has been long recognized as a major treatment-related adverse …

Background Hepatitis B is one of the most common infectious diseases worldwide. In
patients undergoing immunosuppressive therapy such as rheumatic diseases, reactivation …

The aims of this paper are to report hepatitis B virus reactivation in 12 patients with
rheumatic disease undergoing immunosuppressive therapy and to evaluate whether pre …

Aim To identify the incidence and risk factors for hepatitis B virus (HBV) reactivation in
rheumatoid arthritis (RA) patients with resolved HBV receiving biological disease‐modifying …